Skip to main content
. 2021 Apr 28;59(9):909–915. doi: 10.1093/mmy/myab021

Table 2.

Main characteristics of people living with HIV/AIDS with asymptomatic positive cryptotoccal antigen finger-prick lateral flow assay in Santarém Municipality, Brazilian Amazon Basin.

Age/sex Time of HIV diagnosis ART Location Neurological manifestations Concomitant diseases CD4 /μL Total Lymph /μl HIV VL copies/ml CSF India Ink/CSF LFA CrAg Antifungal treatment Outcome 6 months
1 67/M 15 days No Outpatient Neurocognitive disorder Pneumocystis pneumonia NA 312 NA Negative/NA AmB Death day 11
2 48/M 40 days Yes Outpatient None Chronic diarrhea 382 769 153 Negative/positive Fluconazole Alive
3 45/M 16 days No Hospitalized Headache, motor deficit Pulmonary tuberculosis/Cerebral toxoplasmosis/Pneumocystis pneumonia 73 329 2003 Negative/NA None Alive
4 30/F Same day No Outpatient None Pneumocystis pneumonia NA 425 466.963 Negative/negative Fluconazole Alive
5 25/M Same day No Hospitalized Headache Pneumocystis pneumonia/Chronic diarrhea NA 332 NA NA/NA None Lost to follow-up
6 52/F 1 day No Outpatient None Pneumocystis pneumonia/Oroesofageal candidiasis NA 271 NA NA/NA AmB Death day 12
7 33/M 2 days No Outpatient None None 119 2148 NA NA/NA Fluconazole Alive
8 63/F 4 years Yes Hospitalized Altered mental status Pneumocystis pneumonia/Bacterial Pneumonia 230 511 <40 Negative/Negative Fluconazole Death day 22
9 57/F 15 days No Hospitalized Headache, motor deficit Cerebral toxoplasmosis/Oroesophageal candidiasis 74 662 295 NA/NA None Alive
10 36/M 2 months Yes Hospitalized Headache Pulmonary tuberculosis/Oroesophageal candidiasis NA 70 NA Negative/Negative Fluconazole Lost to follow-up
11 35/M 3 months No Hospitalized Altered mental status Plasmablastic lymphoma/Oroesophageal candidiasis NA 582 NA Negative/Negative Fluconazole Death day 22

NA = not available; ART = antiretroviral therapy; CSF = cerebrospinal fluid; Lymph = lymphocyte count; LFA, lateral flow assay; CrAg = cryptococcal antigen; AmB = amphotericin B deoxycholate.